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EDITORIALMeta-analysis:  Indispensable  tool  or  weapon  of  mass
confusion?
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oMeta-analysis  is  a  mathematical  methodology  developed  in
education  science  and  psychology  research  in  the  1970s  and
applied  in  medicine  since  the  1980s.  The  aim  is  to  combine
data  from  different  studies  on  a  given  topic  so  as  to  produce
a  quantiﬁed  synthesis.  Meta-analyses  are  often  very  helpful
in  orthopedics  as  it  is  not  easy  for  us  to  put  together  large
cohorts  with  a  minimum  follow-up  that  is  long  enough  to
be  convincing  (implants,  surgery  in  young  mobile  patients,
etc.).  A  meta-analysis  means  collating  several  separate
studies  so  as  to  increase  the  number  of  patients  and  thus
provide  a  more  precise  answer  to  the  question  under  study.
This  requires  as  exhaustive  a  search  of  publications  on  the
topic  of  interest  as  possible,  whether  they  are  referenced
or  not:  it  is  up  to  the  author  to  compile  the  ‘‘list  of  listed
references’’  from  the  selected  articles,  including  books,
congress  abstracts  or  whatever.  The  studies  included  in
the  meta-analysis  should  apply  closely  related  experimental
conditions  but  may  have  different  or  indeed  contradictory
results.  A  meta-analysis  is  not  the  same  thing  as  a  sys-
tematic  analysis  of  the  literature,  which  reviews  articles
following  strict  selection  criteria  but  is  not  necessarily  seek-
ing  to  be  exhaustive  and  does  not  enable  treatment  effects
(in  therapeutic  trials)  to  be  quantiﬁed,  as  the  data  are
not  aggregated  and  weighted  by  any  mathematical  method.
Meta-analysis  thus  represents  a  distinct  progress  over  mere
literature  reviews.
In  theory,  a  meta-analysis  should  be  able  to  resolve  a
doubt  or  worry  as  to  the  effectiveness  of  such  and  such
a  treatment  or  diagnostic  test  when  results  prove  contra-
dictory,  and  should  seek  to  account  for  the  discrepancies.
The  method  may  also  serve  to  show  that  the  present  state
of  knowledge  does  not  allow  any  conclusion  to  be  drawn
and  that  further  research  is  called  for.  Adding  together  and
weighting  different  cohorts  enables  subgroup  analysis  and
thus  screening  for  patient  groups  able  to  obtain  maximal
beneﬁt  from  a  given  treatment,  or  on  the  contrary  for  whom
it  should  be  contraindicated.
Meta-analysis  is  thus  genuine  research  based  on  system-
atic  weighted  study  of  the  included  cohorts  or  groups,  rather
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linical  study,  it  must  adhere  to  a  rigorous  methodology,
s  it  is  not  exempt  from  possible  bias  such  as  incomplete
xhaustiveness  in  study  retrieval,  publication  bias  (negative
esults  being  less  frequently  published),  poor  quality  in  the
elected  studies  or  studies  lacking  data  on  the  parameters
nder  analysis.
To  clarify  meta-analysis  methodology,  a  group  of  clini-
ians,  methodologists  and  statisticians  drew  up  a  structured
iagram  of  meta-analysis  construction  and  validation,  with
 precise  and  rigorous  check-list  that  was  updated  in  2009
nd  named  Preferred  Reporting  Items  for  Systematic  reviews
nd  Meta-Analyses  (PRISMA)  [1]. The  Cochrane  collaboration
lso  produced  a  strict  methodology,  the  Cochrane  Handbook
or  Systematic  Reviews  of  Interventions,  with  computerized
ools  for  systematic  data  extraction  (GRADEpro  and  GRADE-
roﬁler)  and  statistical  analysis  in  line  with  good  practice
uidelines  (Review  Manager  software:  RevMan  Version  5.1;
he  Nordic  Cochrane  Center,  The  Cochrane  Collaboration,
openhagen,  Denmark).  The  present  references  [2]  and  [3]
lso  contain  important  elements  for  statistical  analysis,  and
eference  [4]  contains  a critique  of  quality  scoring  as  a
eans  of  selecting  studies  for  meta-analysis.
As  the  technique  grows  ever  more  popular,  the  number  of
rticles  and  repetitions  of  meta-analyses  on  identical  topics
an  be  seen  to  be  increasing,  sometimes  with  divergent  ﬁnd-
ngs.  This  causes  real  problems,  as  it  is  often  very  hard,  from
he  information  to  be  found  in  the  article,  to  analyze  and
nderstand  the  reasons  for  such  divergence.  Some  biases
re  easy  to  detect,  such  a  selecting  or  not  selecting  certain
rticles  (omission,  differences  in  selection  criteria  laid  out
n  the  Methods  sections,  or  just  good  old-fashioned  bias),
ut  usually  the  reasons  are  more  subtle  and  it  requires  the
recious  help  of  a statistician  or  epidemiologist  to  trace  to
rigin  of  the  discordance  (which  usually  comes  down  to  lack
f  exhaustiveness  and  the  variable  quality  and  heterogene-
ty  of  the  included  studies,  or,  as  the  saying  goes,  ‘‘Garbage
n,  garbage  out’’).  This  is  true  for  all  large-circulation  jour-
als,  and  has  incited  the  Journal  of  Bone  and  Joint  Surgery
served.
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nd  Clinical  Orthopaedics,  to  name  but  two,  to  draw  up  rules
hat  any  meta-analysis  being  submitted  must  adhere  to.
Apart  from  the  methodological  principles  mentioned
bove,  it  would  therefore  seem  useful  to  point  out  a few
asics.
1)  The  ‘‘danger’’  of  meta-analysis  lies  not  so  much  in  the
tool  itself  as  the  undue  conﬁdence  the  ﬁnal  results  may
inspire.  We  need  to  learn  to  interpret  meta-analyses  in
the  light  of  their  limitations,  as  with  any  clinical  trial.
It  must  always  be  borne  in  mind  that  the  qualitative
description  of  the  included  studies  and  the  limitations
of  the  literature  highlighted  by  the  meta-analysis  (het-
erogeneity,  publication  bias,  etc.)  may  well  be  much
more  important  than  the  ﬁnal  result  itself.  We  need  to
change  our  way  of  critical  reading!
2)  One  needs  to  be  very  careful  in  writing  up  a  meta-
analysis:  although  very  often  read  only  by  practitioners
or  researchers,  it  may  also  fall  into  the  hands  of  a  public
health  or  political  decision-maker.  Depending  on  its  rigor
and  the  viewpoint  taken,  a  given  meta-analysis  may
be  more  or  less  informative,  more  or  less  debatable,
and  thus  go  beyond  the  strict  ﬁeld  of  evidence-based
medicine.
3)  Before  submitting  a  meta-analysis,  like  any  clinical
study,  one  single  question  has  to  be  raised:  is  the  ques-
tion  that  is  being  addressed  one  of  everyday  practice
and  are  the  results  representative  of  the  patients  actu-
ally  encountered  in  real  life?  I.e.,  are  the  results  of
clinical  interest?
4)  To  avoid  the  above-mentioned  sources  of  bias,  a meta-
analysis  must  imperatively  be  seen  as  a  multidisciplinary
undertaking,  involving  clinicians  from  the  ﬁeld  in  ques-
tion  and  methodologists  (including  statisticians  and/or
epidemiologists).  Whereas  an  original  clinical  study  nec-
essarily  involves  clinical  specialists  in  its  ﬁeld,  who  are
the  only  ones  to  have  access  to  the  relevant  popula-
tion,  a  meta-analysis  may  in  principle  be  conducted  by
a  physician,  a  methodologist  or  a  decision-maker  with-
out  extensive  knowledge  of  the  pathology  concerned  or
of  the  ever  more  complex  techniques  of  surgery;  ‘‘I  may
not  practice  or  have  any  experience,  but  I  can  talk  about
this  and  tell  you  what  you  should  be  doing’’  is  only  justEditorial
an  exaggeration.  Such  an  attitude,  taking  no  account  of
the  speciﬁcities  of  surgical  practice,  can  only  lead  to
mistaken  interpretations  and  conclusions.
Finally,  should  we  not  on  the  one  hand  begin  our  research
y  analyzing  the  various  meta-analyses  and  draw  up  a
esearch  protocol  for  future  studies  so  as  to  be  able  to
rovide  a  deﬁnite  answer  to  a  given  question  and  avoid
dding  yet  another  study  to  all  those  already  available,
ncreasing  the  risk  of  confusion  and  disagreement,  and  on
he  other  hand  limit  the  number  of  patients  included  in  out
rials  and  research?
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